These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24731753)

  • 1. T cells infiltrate the liver and kill hepatocytes in HLA-B(∗)57:01-associated floxacillin-induced liver injury.
    Wuillemin N; Terracciano L; Beltraminelli H; Schlapbach C; Fontana S; Krähenbühl S; Pichler WJ; Yerly D
    Am J Pathol; 2014 Jun; 184(6):1677-82. PubMed ID: 24731753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA haplotype determines hapten or p-i T cell reactivity to flucloxacillin.
    Wuillemin N; Adam J; Fontana S; Krähenbühl S; Pichler WJ; Yerly D
    J Immunol; 2013 May; 190(10):4956-64. PubMed ID: 23596311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Animal Model of Abacavir-Induced HLA-Mediated Liver Injury.
    Song B; Aoki S; Liu C; Susukida T; Ito K
    Toxicol Sci; 2018 Apr; 162(2):713-723. PubMed ID: 29319822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury.
    Monshi MM; Faulkner L; Gibson A; Jenkins RE; Farrell J; Earnshaw CJ; Alfirevic A; Cederbrant K; Daly AK; French N; Pirmohamed M; Park BK; Naisbitt DJ
    Hepatology; 2013 Feb; 57(2):727-39. PubMed ID: 22987284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promiscuous T-cell responses to drugs and drug-haptens.
    Yaseen FS; Saide K; Kim SH; Monshi M; Tailor A; Wood S; Meng X; Jenkins R; Faulkner L; Daly AK; Pirmohamed M; Park BK; Naisbitt DJ
    J Allergy Clin Immunol; 2015 Aug; 136(2):474-6.e8. PubMed ID: 25910715
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of mouse models with restricted HLA-B∗57:01 presentation for the study of flucloxacillin-driven T-cell activation and tolerance in liver injury.
    Ananthula S; Krishnaveni Sivakumar K; Cardone M; Su S; Roderiquez G; Abuzeineh H; Kleiner DE; Norcross MA; Puig M
    J Allergy Clin Immunol; 2023 Aug; 152(2):486-499.e7. PubMed ID: 37030592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
    Kaniwa N; Saito Y
    J Hum Genet; 2013 Jun; 58(6):317-26. PubMed ID: 23635947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety of flucloxacillin in HIV-infected patients with positive HLA-B*5701 genotype.
    Vera JH; Naous N; Mackie N; Winston A; Cooke G
    AIDS; 2013 Jan; 27(3):484-5. PubMed ID: 23032409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic association studies in drug-induced liver injury.
    Daly AK; Day CP
    Semin Liver Dis; 2009 Nov; 29(4):400-11. PubMed ID: 19826974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles.
    Nicoletti P; Aithal GP; Chamberlain TC; Coulthard S; Alshabeeb M; Grove JI; Andrade RJ; Bjornsson E; Dillon JF; Hallberg P; Lucena MI; Maitland-van der Zee AH; Martin JH; Molokhia M; Pirmohamed M; Wadelius M; Shen Y; Nelson MR; Daly AK;
    Clin Pharmacol Ther; 2019 Jul; 106(1):245-253. PubMed ID: 30661239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology of immune-mediated liver injury.
    Dienes HP; Drebber U
    Dig Dis; 2010; 28(1):57-62. PubMed ID: 20460891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-B*5701 and flucloxacillin associated drug-induced liver disease.
    Phillips EJ; Mallal SA
    AIDS; 2013 Jan; 27(3):491-2. PubMed ID: 23291545
    [No Abstract]   [Full Text] [Related]  

  • 13. Conjugation of human serum albumin and flucloxacillin provokes specific immune response in HLA-B*57:01 transgenic mice.
    Gao Y; Song B; Aoki S; Ito K
    Immunol Lett; 2022 Sep; 249():5-11. PubMed ID: 35963284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Flucloxacillin-Specific CD8+ T-Cells With the Potential to Promote Hepatocyte Cytotoxicity in a Mouse Model.
    Nattrass R; Faulkner L; Vocanson M; Antoine DJ; Kipar A; Kenna G; Nicolas JF; Park BK; Naisbitt DJ
    Toxicol Sci; 2015 Jul; 146(1):146-56. PubMed ID: 25877613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of immune reactions in drug-induced liver injury (DILI).
    Ju C; Reilly T
    Drug Metab Rev; 2012 Feb; 44(1):107-15. PubMed ID: 22235834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting idiosyncratic drug-induced liver injury: some recent advances.
    Chen M; Borlak J; Tong W
    Expert Rev Gastroenterol Hepatol; 2014 Sep; 8(7):721-3. PubMed ID: 24857265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
    Daly AK; Donaldson PT; Bhatnagar P; Shen Y; Pe'er I; Floratos A; Daly MJ; Goldstein DB; John S; Nelson MR; Graham J; Park BK; Dillon JF; Bernal W; Cordell HJ; Pirmohamed M; Aithal GP; Day CP; ;
    Nat Genet; 2009 Jul; 41(7):816-9. PubMed ID: 19483685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Floxacillin-induced cholestatic hepatitis with evidence of lymphocyte sensitization.
    Victorino RM; Maria VA; Correia AP; de Moura C
    Arch Intern Med; 1987 May; 147(5):987-9. PubMed ID: 3579450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin aggravates immune-mediated liver injury in mice.
    Volarevic V; Misirkic M; Vucicevic L; Paunovic V; Simovic Markovic B; Stojanovic M; Milovanovic M; Jakovljevic V; Micic D; Arsenijevic N; Trajkovic V; Lukic ML
    Arch Toxicol; 2015 Mar; 89(3):437-50. PubMed ID: 24770553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated Peptides.
    Puig M; Ananthula S; Venna R; Kumar Polumuri S; Mattson E; Walker LM; Cardone M; Takahashi M; Su S; Boyd LF; Natarajan K; Abdoulaeva G; Wu WW; Roderiquez G; Hildebrand WH; Beaucage SL; Li Z; Margulies DH; Norcross MA
    Front Immunol; 2020; 11():629399. PubMed ID: 33633747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.